Compare · GH vs UNH
GH vs UNH
Side-by-side comparison of Guardant Health Inc. (GH) and UnitedHealth Group Incorporated (UNH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GH and UNH operate in Medical Specialities (Health Care), so they compete in similar markets.
- UNH is the larger of the two at $355.98B, about 16.1x GH ($22.13B).
- Over the past year, GH is up 159.7% and UNH is up 32.0% - GH leads by 127.8 points.
- GH has been more active in the news (15 items in the past 4 weeks vs 7 for UNH).
- Both have 25 recent analyst ratings on file.
- Company
- Guardant Health Inc.
- UnitedHealth Group Incorporated
- Price
- -
- -
- Market cap
- $22.13B
- $355.98B
- 1M return
- +13.31%
- -5.03%
- 1Y return
- +159.72%
- +31.97%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- News (4w)
- 15
- 7
- Recent ratings
- 25
- 25
Guardant Health Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing tests from its LUNAR program for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; LUNAR-2 test for the early detection of cancer in asymptomatic individuals eligible for cancer screening; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for residual disease and recurrence monitoring; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Daiichi Sankyo has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Latest GH
- Co-Chief Executive Officer Talasaz Amirali sold $6,343,384 worth of shares (37,500 units at $169.16) (SEC Form 4)
- Director Mignone Roberto converted options into 264 shares, increasing direct ownership by 3% to 10,010 units (SEC Form 4)
- Guardant Health to Appeal Federal District Court Judgment
- TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University of Washington More Than $245.2 Million in Damages, Accrued Royalties and Interest
- Director Hidalgo Medina Manuel converted options into 232 shares, increasing direct ownership by 5% to 4,788 units (SEC Form 4)
- Director Tariq Musa converted options into 250 shares and sold $18,148 worth of shares (116 units at $156.45), increasing direct ownership by 1% to 11,316 units (SEC Form 4)
- Chief People Officer Monroe Terilyn J. exercised 46,300 shares at a strike of $22.70 and sold $7,645,218 worth of shares (46,300 units at $165.12) (SEC Form 4)
- Co-Chief Executive Officer Eltoukhy Helmy gifted 35,000 shares and received a gift of 35,000 shares (SEC Form 4)
- Co-Chief Executive Officer Talasaz Amirali gifted 75,000 shares and received a gift of 75,000 shares (SEC Form 4)
- Chief Legal Officer Saia John G. gifted 800 shares, decreasing direct ownership by 2% to 38,991 units (SEC Form 4)
Latest UNH
- Chief Executive Officer, Optum Conway Patrick Hugh sold $455,910 worth of shares (1,169 units at $390.00), decreasing direct ownership by 7% to 15,328 units (SEC Form 4)
- UnitedHealthcare Expands Access to Child and Family Behavioral Coaching to 13 Million Commercial Members
- Chief Accounting Officer Stankiewicz Dennis Andrew covered exercise/tax liability with 233 shares, decreasing direct ownership by 2% to 10,058 units (SEC Form 4)
- UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
- SEC Form 10-Q filed by UnitedHealth Group Incorporated
- Chief Executive Officer, Optum Conway Patrick Hugh sold $205,000 worth of shares (500 units at $410.00), decreasing direct ownership by 3% to 16,497 units (SEC Form 4)
- SEC Form SCHEDULE 13G filed by UnitedHealth Group Incorporated
- UnitedHealth Group Partners with UT Health Sciences to Expand Health Hubs to More Communities Across Tennessee
- UnitedHealth upgraded by Robert W. Baird with a new price target
- UnitedHealth Group Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits